Detalhe da pesquisa
1.
Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.
J Infect Dis
; 228(9): 1253-1262, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439701
2.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065705
3.
Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
J Infect Dis
; 225(2): 327-331, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34888662
4.
Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
PLoS Pathog
; 8(8): e1002895, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952447
5.
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
Hum Vaccin Immunother
; 20(1): 2301632, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206168
6.
Treatment with monoclonal antibodies against Clostridium difficile toxins.
N Engl J Med
; 362(3): 197-205, 2010 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20089970
7.
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine
; 41(11): 1875-1884, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781334
8.
Towards a population-based threshold of protection for COVID-19 vaccines.
Vaccine
; 40(2): 306-315, 2022 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933765
9.
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
Lancet Infect Dis
; 22(7): 990-1001, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447085
10.
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Vaccine
; 39(32): 4423-4428, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210573
11.
Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.
J Virol
; 83(23): 12473-82, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19759151
12.
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Vaccine
; 38(31): 4783-4791, 2020 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507409
13.
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
J Virol Methods
; 128(1-2): 21-8, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15885812
14.
History of passive antibody administration for prevention and treatment of infectious diseases.
Curr Opin HIV AIDS
; 10(3): 129-34, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25760933
15.
High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody.
PLoS One
; 9(6): e100325, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24956119
16.
Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1.
PLoS One
; 8(4): e61210, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23613814
17.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-54649
18.
G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Antiviral Res
; 91(2): 187-94, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21693135
19.
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Vaccine
; 28(4): 965-9, 2010 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19941990
20.
Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
Vaccine
; 25(15): 2800-10, 2007 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17240489